As of close of business last night, Procept BioRobotics Corp’s stock clocked out at $54.08, down -2.93% from its previous closing price of $55.72. In other words, the price has decreased by -$2.93 from its previous closing price. On the day, 1.23 million shares were traded. PRCT stock price reached its highest trading level at $56.865 during the session, while it also had its lowest trading level at $54.0358.
Ratios:
To gain a deeper understanding of PRCT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.74 and its Current Ratio is at 8.94. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on July 09, 2025, initiated with a Overweight rating and assigned the stock a target price of $70.
On December 02, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $105.Morgan Stanley initiated its Overweight rating on December 02, 2024, with a $105 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 10 ’25 when Desai Antal Rohit sold 25,000 shares for $63.91 per share. The transaction valued at 1,597,711 led to the insider holds 64,363 shares of the business.
Desai Antal Rohit sold 25,000 shares of PRCT for $1,584,525 on Jun 11 ’25. The Director now owns 39,363 shares after completing the transaction at $63.38 per share. On Jun 12 ’25, another insider, Desai Antal Rohit, who serves as the Director of the company, sold 25,000 shares for $61.49 each. As a result, the insider received 1,537,256 and left with 14,363 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRCT now has a Market Capitalization of 2992452608 and an Enterprise Value of 2758056960. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.01 while its Price-to-Book (P/B) ratio in mrq is 7.68. Its current Enterprise Value per Revenue stands at 11.071 whereas that against EBITDA is -30.349.
Stock Price History:
The Beta on a monthly basis for PRCT is 1.05, which has changed by -0.13684964 over the last 52 weeks, in comparison to a change of 0.17535925 over the same period for the S&P500. Over the past 52 weeks, PRCT has reached a high of $103.81, while it has fallen to a 52-week low of $47.04. The 50-Day Moving Average of the stock is -8.04%, while the 200-Day Moving Average is calculated to be -21.60%.
Shares Statistics:
It appears that PRCT traded 889.18K shares on average per day over the past three months and 1410260 shares per day over the past ten days. A total of 55.28M shares are outstanding, with a floating share count of 52.60M. Insiders hold about 4.93% of the company’s shares, while institutions hold 91.96% stake in the company. Shares short for PRCT as of 1752537600 were 6823424 with a Short Ratio of 7.67, compared to 1749772800 on 6716837. Therefore, it implies a Short% of Shares Outstanding of 6823424 and a Short% of Float of 14.63.
